| IMPURITY | CAS NO |
|---|---|
| Albendazole Methyl 5-propylthio-2-benzimidazolecarbamate | 54965-21-8 |
| Albendazole EP Impurity A 5-(Propylthio)-1H-benzimidazol-2-amine | 80983-36-4 |
| Albendazole EP Impurity B Methyl [5-(propylsulphinyl)-1Hbenzimidazol-2-yl] carbamate | 54029-12-8 |
| Albendazole EP Impurity C Albendazole Sulfone ; Methyl [5-(propylsulphonyl) -1Hbenzimidazol-2-yl]carbamate | 75184-71-3 |
| Albendazole EP Impurity D Desmethoxycarbonyl Albendazole Sulfone | 80983-34-2 |
| Allopurinol 1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one | 315-30-0 |
| Allopurinol EP Impurity A Allopurinol USP RC A ; 5-amino-1H-pyrazole-4-carboxamide | 27511-79-1 |
| Allopurinol EP Impurity B Allopurinol USP RC B ; 5-(formylamino)-1H-pyrazole-4 -carboxamide | 80983-34-2 |
| Albendazole EP Impurity D Desmethoxycarbonyl Albendazole Sulfone | 22407-20-1 |
| Allopurinol EP Impurity C Allopurinol USP RC C ; 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4- carboxamide | 80983-34-2 |
| Albendazole EP Impurity D Desmethoxycarbonyl Albendazole Sulfone | 1346604-13-4 |
| Allopurinol EP Impurity D Allopurinol USP RC D ; ethyl 5-amino-1H-pyrazole-4-carboxylate | 6994-25-8 |
| Allopurinol EP Impurity E Allopurinol USP RC E ; ethyl 5-(formylamino)-1H-pyrazole-4- carboxylate | 31055-19-3 |
| Amlodipine 3-ethyl 5-Methyl 2-((2-aMinoethoxy)Methyl)-4-(2-chlorophenyl) 6-Methyl-1,4-dihydropyridine-3,5-dicarboxylate Maleate | 88150-47-4 |
| Amlodipine EP impurity A Amlodipine USP RC D,Phthaloyl Amlodipine Desmethoxycarbonyl Albendazole Sulfone | 88150-62-3 |
| Amlodipine EP impurity B Methylaminophthaloyl Amlodipine; N-[2-[(Methylamino)carbonyl]benzoyl] Amlodipine | 721958-72-1 |
| Amlodipine EP Impurity D 3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)- 6-methylpyridine-3,5-dicarboxylate benzenesulfonate | 113994-41-5 |
| Amlodipine EP Impurity E Amlodipine Diethyl Ester; 2-[(2-Aminoethoxy)methyl]-4-(2- chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic Acid 3,5-Diethyl Ester | 140171-65-9 |
| Amlodipine EP Impurity F Amlodipine Dimethyl Ester; 2-[(2-Aminoethoxy)methyl]-4-(2- chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic Acid 3,5-dimethyl Ester | 140171-66-0 |
| Amlodipine EP impurity G Dimethyl 4-(2-Chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine- 3,5-dicarboxylate | 43067-01-02 |
| Amlodipine EP Impurity H 2-Carboxybenzoyl Amlodipine | 318465-73-5 |
| Amlodipine USP RC A (3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)- 6-methyl-3,5-pyridinedicarboxylate fumarate) | 2138811-33-1 |
| Amiodarone (2-Butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5- diiodophenyl] methanone Hydrochloride | 19774-82-4 |
| 2-Butyl Benzofuran | 4265-27-4 |
| 2-Butyl-3-(2-Methoxy benzoyl) benzofuran (2-butyl-1-benzofuran-3-yl)(2-methoxyphenylmethanone | NA |
| 2-Butyl-3-(3-Methoxy benzoyl) benzofuran (2-butyl-1-benzofuran-3-yl)(3-methoxyphenylmethanone | NA |
| Amoxicillin Trihydrate (2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetylamino]- 3,3-dimethyl-7-oxo-4-thia-1azabicyclo[3.2.0]heptane-2- carboxylic acid trihydrate | 61336-70-7 |
| Amoxicillin EP Impurity A Amoxicillin Related Compound A ; 6-APA ; (+)-6- Aminopenicillanic acid ;(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo- 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | 551-16-6 |
| Apremilast (S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl) -2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide | 608141-41-9 |
| Apremilast Impurity 1 3-Ethoxy-4-methoxy-[(methylsulfonyl)methyl]-(S)- benzenemethanamine | 608141-42-0 |
| Aripiprazole 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4- dihydroquinolin-2(1H)-one | 129722-12-9 |
| Aripiprazole EP Impurity A 3,4-Dihydro-7-hydroxyquinoline-2(1H)-one | 22246-18-0 |
| Aripiprazole EP Impurity B 1-(2,3-dichlorophenyl)piperazine ; 4-(2,3-Dichlorophenyl)-1- piperazinebutanol Hydrochloride | 119532-26-2 |
| Aripiprazole EP Impurity E Aripiprazole related compound G ; Dehydro Aripiprazole Impurity, 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl) butoxy)quinolin-2(1H)-one, | 129722-25-4 |
| Aripiprazole Related Compound B 3,4-Dihydro-7-(4-hydroxybutoxy)-2(1H)-quinolinone | 889443-20-3 |
| Chlorobutoxy Dihydroquinolinone 7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone; 7-(4- Chlorobutoxy)-3,4-dihydro-C2(1H)-quinoline | 120004-79-7 |
| Aripiprazole Bromobutoxyquinoline Impurity 7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one | 129722-34-5 |
| Aripiprazole Quinolinone Impurity 7-Hydroxyquinoline-(1H)-2-one , 7-Hydroxy-2(1H)-quinolinone | 70500-72-0 |
| Aripiprazole Impurity 6 7-Hydroxyquinoline-(1H)-2-one , 7-Hydroxy-2(1H)-quinolinone | 63386-61-8 |
| Aripiprazole Impurity 7 N1-(2-chloroethyl)-N2-(2,3-dichlorophenyl)ethane-1,2-diamine hydrochloride | NA |
| Atenolol 2-[4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl]acetamide | 29122-68-7 |
| Atenolol EP Impurity A 2-(4-Hydroxyphenyl)acetamide | 17194-82-0 |
| Atenolol EP Impurity B 2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide | 61698-76-8 |
| Atenolol EP Impurity C 2-[4-[[(2RS)-oxiran-2-yl]methoxy]phenyl]acetamide | 29122-69-8 |
| Atenolol EP Impurity D 2-[4-[(2RS)-3-chloro-2-hydroxypropoxy]phenyl]acetamide | 115538-83-5 |
| Atenolol EP Impurity E 2,2′-[2-Hydroxypropan-1,3-diylbis(oxy-4,1- phenylene)diacetamide | 141650-31-9 |
| Atenolol EP Impurity F 2,2′-[(1-Methylethyl)iminobis(2-hydroxypropan-3,1diyloxy-4,1- phenylene)]diacetamide | 87619-83-8 |
| Atenolol EP Impurity J 2-(4-(3-amino-2-hydroxypropoxy)phenyl)acetamide | 81346-71-6 |
| Atomoxetine Hydrochloride (R)-N-Methyl-(2-methylphenoxy)benzenepropanamine Hydrochloride | 82248-59-7 |
| Atomoxetine EP Impurity A N-methyl-3-phenoxy-3-phenylpropan-1-amine hydrochloride | 873310-33-9 |
| Atomoxetine EP Impurity C Atomoxetine USP RC C ; p-Methyl Atomoxetine HCl | 1643684-06-3 / 1010818-96-8 |
| Atomoxetine EP Impurity D Atomoxetine USP RC B ; m-Methyl Atomoxetine HCl | 1643684-05-2/ 1643684-02-9 |
| Atomoxetine EP Impurity E L-Mandelic Acid ; (S)-(+)-Mandelic Acid ; (2S)-2-Hydroxy-2- phenylacetic acid | 17199-29-0 |
| Atomoxetine EP Impurity H Atomoxetine USP RC A ; 3-(Methylamino)-1-phenylpropan-1-ol | 42142-52-9 |
| Atomoxetine Urea Impurity (R)-1-Methyl-1-(3-phenyl-3-(o-tolyloxy)propyl)urea | NA |
| Atorvastatin calcium salt Calcium (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3- phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]- 3,5dihydroxyheptanoate | 134523-00-5 |
| Atorvastatin EP Impurity F (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl) -3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5- dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoic acid | 887196-24-9 |
| Atorvastatin Acid t-Butyl Ester (3R,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2isopropyl-4- phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid t-butyl ester | 134395-00-9 |
| Atorvastatin Acid Methyl Ester (3R,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl- 4-phenyl-1H-pyrrol-1-yl]-3,5 -dihydroxyheptanoic acid methyl ester | 345891-62-5 |
| Atropine Sulfate Atropine Sulfate Monohydrate | 5908-99-6 |
| Atropine EP Impurity A Apoatropine, 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2- phenylacrylate | 500-55-0 |
| Atropine EP Impurity B (1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2- phenylpropanoate | 16839-98-8 |
| Atropine EP Impurity C Tropic acid, 2-Phenylhydracrylic acid, 3-Hydroxy-2- phenylpropionic acid | 552-63-6 |
| Azilsartan medoxomil potassium | 863031-24-7 863031-21-4 |
| Azilsartan 1-[[2’-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl) [1,1’-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7- carboxylic Acid | 147403-03-0 |
| Azilsartan Impurity A methyl 1-((2′-carbamoyl-[1,1′-biphenyl]-4-yl)methyl) -2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | 147404-76-0 |
| Azilsartan Impurity B 1-((2′-carbamoyl-[1,1′-biphenyl]-4-yl)methyl) -2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid | 1696392-11-6 |
| Azilsartan Impurity C 2-ethoxy-1-((2′-(N’-hydroxycarbamimidoyl) -[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid | 397836-49-5 |
| Azilsartan Impurity D 3-((2′-(N’-hydroxycarbamimidoyl)-[1,1′-biphenyl]-4-yl) methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | 1821386-21-3 |
| Azilsartan Impurity M 1-((2′-cyano-[1,1′-biphenyl]-4-yl)methyl) -2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid | 632322-61-3 |
| Azilsartan Ethyl Impurity ethyl 2-ethoxy-1-((2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) -[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7- carboxylate | 1403474-70-3 |
| Azilsartan Ethyl Ring-opening Impurity ethyl(Z)-2-ethoxy-1-((2′-(N’- ((ethoxycarbonyl)oxy)carbamimidoyl)-[1,1′-biphenyl]-4- yl)methyl)-1H-benzo[d] imidazole-7-carboxylate | 1403474-75-8 |
| Azilsartan Impurity 1 methyl 1-((2′-cyano-[1,1′-biphenyl]-4-yl)methyl) -2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | 139481-44-0 |
| Azilsartan Impurity 4 Azilsartan Methyl Ester ; methyl 2-ethoxy-1-((2′-(5-oxo-4,5- dihydro-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl) methyl)-1H- benzo[d]imidazole-7-carboxylate | 147403-52-9 |
| Alfuzosin HCl (RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2- yl)(methyl)amino]propyl]tetrahydrofuran-2-carboxamide hydrochloride | 81403-68-1 |
| Alfuzosin EP Impurity A Alfuzosin USP Related Compound A ; Alfuzosin Tetradehydro Impurity | 98902-29-5 |
| Alfuzosin EP Impurity B 2-chloro-6,7-dimethoxyquinazolin-4-amine ; 4-Amino-2-chloro- 6,7-dimethoxyquinazoline ; 2-Chloro-6,7-dimethoxy-4- quinazolinamine | 23680-84-4 |
| Alfuzosin EP Impurity C (RS)-N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)amino] propyl]-N-methyltetrahydrofuran-2-carboxamide hydrochloride | 72104-34-8 |
| Alfuzosin EP Impurity D Alfuzosin Aminopropyl Impurity ; Alfuzosin USP Related | 81403-69-2 |
| Alfuzosin EP Impurity E N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)aminopropyl]formamide hydrochlorideyl)(methyl)aminopropyl]formamide hydrochloride | 1026411-59-5 |
| Alfuzosin EP Impurity F 6,7-dimethoxy-N2,N2-dimethylquinazoline-2,4-diamine ; 4- Amino-2-(dimethylamino)-6,7-dimethoxy-quinazoline | 19216-53-6 |
| Alprazolam 8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepine | 28981-97-7 |
| Alprazolam Impurity E Prazepam Imp. C (EP), Clorazepate Imp. A (EP), , 2-Amino-5- chloro benzophenone | 719-59-5 |
| Althiazide (3R)-3-[(Allylsulfanyl)methyl]-6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide | 5588-16-9 |
| 3-Des(allylthio)methyl-3-chloromethyl Althiazide 6-Chloro-3-(chloromethyl)-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-Dioxide | 1824-47-1 |
| Amoxicillin Trihydrate (2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetylamino]- 3,3-dimethyl-7-oxo-4-thia-1azabicyclo[3.2.0]heptane-2- carboxylic acid trihydrate | 61336-70-7 |
| Amoxicillin EP Impurity A Amoxicillin Related Compound A ; 6-APA ; (+)-6- Aminopenicillanic acid ;(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo- 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | 551-16-6 |
| Apixaban 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl] – 4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | 503612-47-3 |
| Apixaban ethyl ester impuity Ethyl 1-(4-Methoxyphenyl)-7-oxo-6- (4-(2-oxopiperidin-1- yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3- carboxylate | 503614-91-3 |
| Apixaban acid impuity 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl) -7-oxo-6-[4-(2-oxo-1- piperidinyl) phenyl]-1H-pyrazolo [3,4-c]pyridine-3-carboxylic acid | 503614-92-4 |
| Apixaban methyl ester impuity 4,5,6,7-Tetrahydro-1- (4-hydroxyphenyl)-7-oxo-6-[4-(2-oxo-1- piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | 1074365-84-6 |
| O-Desmethyl Apixaban 4,5,6,7-Tetrahydro-1-(4-hydroxyphenyl)-7 -oxo-6-[4-(2-oxo-1- piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | 503612-76-8 |
| Apixaban chloro impurity 1-(4-chlorophenyl)-7-oxo-6- [4-(2-oxopiperidin-1-yl)phenyl]- 4,5,6,7-tetrahydro-1H-pyrazolo [3,4-c]pyridine-3-carboxylic Acid Amide | 2029205-64-7 |
| Apixaban Amino Acid Impurity 6-(4-((5-amino-5-oxopentyl)amino)phenyl)-1-(4- methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4- c]pyridine-3-carboxamide | 2187409-01-2 |
| Apixaban morpholine lactum impurity 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6- dihydropyridin-2(1H)-one | 545445-44-1 |
| Apixaban Impurity 2 ethyl (Z)-2-chloro-2-(2-(3-methoxyphenyl)hydrazono)acetate | 405872-78-8 |
| Apixaban Impurity 3 ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7- tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 536759-91-8 |
| Apixaban Impurity 4 ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7- tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503615-07-4 |
| Apixaban Impurity 5 3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)pyridin-2(1H)- one | NA |
| 4,5-Dehydro Apixaban 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)- 6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | 1074549-89-5 |
| Aspartame (S)-3-Amino-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2- yl)amino)-4-oxobutanoic acid | 22839-47-0 |
| Aspartame EP Impurity B (S)-3-Amino-4-(((S)-1-carboxy-2-phenylethyl)amino)-4- oxobutanoic acid | 13433-09-05 |
| Aspartame EP Impurity C Phenylalanine | 150-30-1 |
| Aspartame Impurity 1 Paracetamol EP Impurity K/ Mesalazine EP Impurity A | 123-30-8 |
| Azithromycin | 117772-70-0 |
| Azithromycin EP Impurity B(2R,3R,4S,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C- methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-4,10- dihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3- ( dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-Oxa-6- | 307974-61-4 |
| Brexpiprazole 7-[4-(4-Benzo[b]thien-4-yl-1-piperazinyl)butoxy]-2(1H)- quinolinone | 913611-97-9 |
| Brexpiprazole Impurity 1 1,4-bis(benzo[b]thiophen-4-yl)piperazine | 1420987-86-5 |
| Brexpiprazole N-Oxide 7-[4-(4-Benzo[b]thien-4-yl-1-oxido-1-piperazinyl)butoxy] -2(1H)-quinolinone | 1191900-58-9 |
| Brexpiprazole Impurity 3 5-Hydroxy-2(1H)-quinolinone | 31570-97-5 |
| Brexpiprazole Impurity 4 7-(4-hydroxybutoxy)quinolin-2(1H)-one | 1886188-97-1 |
| Brexpiprazole Impurity 5 7,7′-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) | 2116542-19-7 |
| Brexpiprazole Impurity 6 2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1- yl)butoxy)quinoline | 2138169-93-2 |
| Brexpiprazole Impurity 7 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4- (4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)quinolin-2(1H)- one | 2137823-20-0 |
| Brexpiprazole Impurity 8 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy) -3,4-dihydroquinolin-2(1H)-one | 913612-07-4 |
| Brexpiprazole Impurity 9 7-(4-chlorobutoxy)-1-(4-chlorobutyl)quinolin-2(1H)-one | 2059954-32-2 |
| Brexpiprazole Impurity 10 2,7-bis(4-chlorobutoxy)quinoline | 2060027-95-2 |
| Brexpiprazole Impurity 11 1-(benzo[b]thiophen-4-yl)piperazine hydrochloride | 913614-18-3 |
| Brexpiprazole Impurity 12 7-(4-(piperzin-1-yl)butoxy)quinolin-2(1H)-one | 1849603-58-2 |
| Brexpiprazole Impurity 13 4-Bromo benzo[b]thiophene | 5118-13-8 |
| Brexpiprazole Di-N-Oxide 1-(Benzo[b]thiophen-4-yl)-4-(4-((2-oxo-l,2-dihydroquinolin-7- yl)oxy)butyl) piperazine 1,4-dioxide | 2247155-42-4 |
| Brexpiprazole Impurity 15 7-(4-chloro butoxy)-1H-quinolin-2-one | 913613-82-8 |
| Brexpiprazole Impurity 16 7-(4-Bromobutoxy)-quinoline-2(1H)-one | 203395-59-9 |
| Brexpiprazole Impurity 17 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1- (4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)- one | 2094559-58-5 |
| Brexpiprazole S-Oxide 7-[4-[4-(1-Oxidobenzo[b]thien-4-yl)-1-piperazinyl]butoxy]-2(1H)- quinolinone | 1191900-51-2 |
| 4-Chlorobenzo[b]thiophene | 66490-33-3 |
| Bumetanide 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid | 28395-03-01 |
| Bumetanide EP Impurity A Bumetanide Related Compound B ; 3-nitro-4-phenoxy-5- sulfamoylbenzoic acid | 28328-53-2 |
| Bumetanide EP Impurity B Bumetanide Related Compound A ; 3-amino-4-phenoxy-5- sulfamoylbenzoic acid ; Desbutyl Bumetanide | 28328-54-3 |
| Bumetanide EP Impurity C butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate | 32643-00-8 |
| Bumetanide EP Impurity D 3-((2-ethylhexyl)amino)-4-phenoxy-5-sulfamoylbenzoic acid | 153012-65-8 |
| Bumetanide Impurity 1 Methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate | 57939-04-05 |
| Bupivacaine HCl (2RS)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride | 18010-40-7 |
| Bupivacaine EP Impurity A N-(2,6-Dimethylphenyl)pyridine-2-carboxamide | 5118-13-8 |
| Bupivacaine EP Impurity B (2RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide | 15883-20-2 |
| Bupivacaine EP Impurity C 1-(2,6-Dimethylphenyl)-1,5,6,7-tetrahydro-2H-azepin-2-one | 1797894-80-4 |
| Bupivacaine EP Impurity D (2RS)-2,6-Dichloro-N-(2,6-dimethylphenyl)hexanamide | 1037184-07-8 |
| Bupivacaine EP Impurity E 6-(Butylamino)-N-(2,6-dimethylphenyl)hexanamide | 1330172-81-0 |
| Bupivacaine EP Impurity F 2,6-Dimethylaniline/ ROPIVACAINE RELATED COMPOUND A | 87-62-7 / 21436-98-6 |
| Picolonic acid Pyridine-2-carboxylic Acid | 98-98-6 |
| Buspirone Hydrochloride 8-[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]- decane-7,9-dione hydrochloride | 33386-08-02 |
| Buspirone EP Impurity A Buspirone USP RC A; 2-(Piperazin-1-yl)pyrimidine | 20980-22-7 |
| Buspirone EP Impurity K USP RC K ; 8-Azaspiro[4.5]decane-7,9-dione | 1075-89-4 |
| Busulfan 1,4-Butanediol-dimethanesulfonate Esters; Busulphan | 55-98-1 |
| BISOPROLOL HEMIFUMARATE 1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy] -3-[(1-methylethyl)amino]-2-propanol, Bisoprolol Fumarate | 104344-23-2 / 66722-44-9 |
| Bisoprolol EP Impurity K 2-isopropoxyethyl 4-(2-hydroxy-3- (isopropylamino)propoxybenzoate | 864544-37-6 |
| Bisoprolol EP Impurity L 4-[((2RS)-2-Hydroxy-3-(isopropylamino)- propyl)oxy]benzaldehyde | 29122-74-5 |
| Bisoprolol EP Impurity N (2RS)-1-[4-((2-Ethoxyethoxy)methyl)phenoxy]-3- (isopropylamino)-2-propanol | 1346601-75-9 |
| Bisoprolol EP Impurity Q (2RS)-1-Isopropylamino-3-[4-(2-methoxyethoxy)methyl]- phenoxy-2-propanol | 1346604-00-9 |
| Bisoprolol Carboxylic Acid Impurity 4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid | 72570-70-8 |
| Brimonidine 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine | 91147-43-2 |
| Brimonidine EP Impurity B 5-bromoquinoxalin-6-amine | NA |
| Brimonidine EP Impurity C Quinoxalin-6-amine | 6298-37-9 |
| Brimonidine EP Impurity D 1-(5-bromoquinoxalin-6-yl)thiourea | NA |
| Brimonidine EP Impurity E 2-(5-bromoquinoxalin-6-yl)guanidine | NA |
| Brimonidine EP Impurity F 5-bromo-N-(1H-imidazol-2-yl)quinoxalin-6-amine | NA |
| Brimonidine EP Impurity G 1-(2-aminoethyl)-3-(5-bromoquinoxalin-6-yl)urea | NA |
| β-Carotene 1,3,3-Trimethyl-2-[3,7,12,16-tetramethyl-18-(2,6,6- trimethylcyclohex-1-en-1-yl) octadeca-1,3,5,7,9,11,13,15,17- nonaen-1-yl]cyclohex-1-ene | 7235-40-7 |
| Candesartan Cilexetil 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H- tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7- carboxylate | 145040-37-5 |
| Candesartan EP Impurity A Candesartan Ethyl Ester ; 2-Ethoxy-1-[[2-[1-(triphenylmethyl) -1H-tetrazol-5-yl][1,1?-biphenyl]-4-yl]methyl]-1H- benzimidazole-7-carboxylic Acid ethyl ester | 139481-58-6 |
| Candesartan Bromo N1-Trityl Impurity 5-(4′-Bromomethyl-1,1′-biphenyl-2-yl)-1-triphenylmethyl-1H- tetrazole | 124750-51-2 |
| Carbamazepine 5H-Dibenzo[b,f]azepine-5-carboxamide | 298-46-4 |
| Carbamazepine EP Impurity B 9-Methylacridine | 611-64-3 |
| Carbamazepine EP Impurity D 5H-Dibenzo[b,f]azepine | 256-96-2 |
| Carbamazepine EP Impurity E 10,11-dihydro-5H-dibenzo[b,f]azepine (iminodibenzyl) | 494-19-9 |
| Carbamazepine EP Impurity F H-dibenzo[b,f]azepine-5-carbonyl chloride | 33948-22-0 |
| Celecoxib 4-[5-(4-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl] benzenesulfonamide | 169590-42-5 |
| Celecoxib EP Impurity A USP Related Compound A ; Celecoxib 3-Methyl Analog;4-[5-(3- Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1- yl]benzenesulfonamide | 170570-01-1 |
| Celecoxib EP Impurity B USP Related compound B ; 4-[3-(4-Methylphenyl)-5- trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide | 331943-04-5 |
| Celecoxib 2-Methyl Analog 4-[5-(2-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1- yl]benzenesulfonamide | 170569-99-0 |
| Celecoxib Hydrazine Impurity 4-Sulphonamido phenyl hydrazine hydrochloride | 17852-52-7 |
| Celecoxib Impurity 5 (E)-4-(2-(1-p-tolylethylidene)hydrazinyl)benzenesulfonamide | 1061214-06-9 |
| Celecoxib Impurity 2/ Celecoxib Impurity 6 3-(p-tolyl)-5-(trifluoromethyl)-1H-pyrazole | 948293-46-7/ 219986-64-8 |
| Celecoxib Related Compound 4 4,4,4-trifluoro-1-p-tolylbutane-1,3-dione | 720-94-5 |
| Celecoxib Impurity 7 4,4,4-trifluoro-1-(o-tolyl)butane-1,3-dione | 163266-02-2 |
| 2,4-Dimethyl Celecoxib Impurity 4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl) -1H-pyrazol-1-yl]benzenesulfonamide | 170570-09-9 |
| 3-Methylacetophenone | 585-74-0 |
| 4-Methylacetophenone | 122-00-9 |
| Celecoxib Impurity 3 4-(5-phenyl-3-(trifluoromethyl)-1H-pyrazol-1- yl)benzenesulfonamide | 170569-87-6 |
| Cetirizine Dihydrochloride (RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl] ethoxy]acetic acid dihydrochloride | 83881-52-1 |
| Cetirizine EP Impurity A Cetirizine CBHP Impurity (USP) (RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine | 303-26-4 |
| Cetirizine EP Impurity B (RS)-2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl] acetic acid dihydrochloride | 113740-61-7 |
| Cetirizine EP Impurity C Cetirizine 2-Chloro Analog (RS)-2-[2-[4-[(2- Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy] acetic acid | 83881-59-8 |
| Cetirizine EP Impurity D Cetirizine Dimer Impurity (USP) ; 1,4-bis[(4- Chlorophenyl)phenylmethyl]piperazine dihydrochloride | 346451-15-8 (base) 856841-95-7 (2HCl) |
| Cetirizine EP Impurity F 2-(2-(4-benzhydrylpiperazin-1-yl)ethoxy)acetic acid | 83881-53-2 |
| Cetirizine EP Impurity G Cetirizine Ethanol Impurity ; (R)-2-(4-((4- hlorophenyl)(phenyl)methyl)piperazin-1-yl)ethan-1-ol Dihydrochloride | 164726-80-1 |
| Cetirizne Related Compound A Cetirizine Dihydrochloride Ethyl Ester ; (RS)-2-[2-[4-[(4- Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester | 246870-46-2 (base) |
| Cetirizne Related Compound B Cetirizine Deschloro Ethanol Impurity ; 2-[4- (Diphenylmethyl)piperazin-1-yl]ethanol dihydrochloride | 108983-83-1 |
| Cetirizne Related Compound C Cetirizine Amide Impurity ; (RS)-2-[2-[4-[(4- Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetamide | 200707-85-3 (HCl salt) 83881-37-2 (base) |
| Cetirizine Methyl Ester (USP) (RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl] ethoxy]acetic acid methyl ester dihydrochloride | 83881-46-3 |
| Cetirizine EP Impurity Ethyl Ester (RS)-2-[4-[(4-Chlorophenyl)phenylmethyl] piperazin-1-yl]acetic acid ethyl ester | 19178-83-7 |
| Cetirizine 4-Chlorobenzhydrol Impurity Meclizine USP RC A ; 4-Chlorobenzhydrol | 119-56-2 |
| Cetirizine 4-Chlorobenzophenone Impurity (USP) (4-Chlorophenyl)phenylmethanone | 134-85-0 |
| Cetirizine N-Oxide (RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-oxido-piperazin- 1-yl]ethoxy] acetic acid | 1076199-80-8 |
| Cetirizine 3-Chloro Impurity 3-Chloro Cetirizine Dihydrochloride (USP) ; (RS)-2-[2-[4-[(3- Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy] acetic acid | 1232460-29-5 | 1232460-31-9 |
| (R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine (-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine; (R)-1-(p- Chlorobenzhydryl)piperazine; | 300543-56-0 |
| Cetirizine Ethyl Ester Cetirizine Dihydrochloride Ethyl Ester ; (RS)-2-[2-[4-[(4- Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester | 246870-46-2 |
| 3-Chlorobenzophenone | 1016-78-0 |
| 1-Benzhydrylpiperazine | 841-77-0 |
| 2-Chloro BHP Cetirizine 1-[(2-Chlorophenyl)phenylmethyl]piperazine | 109036-15-9 |
| 3-Chloro BHP Cetirizine 1-[(3-Chlorophenyl)phenylmethyl]piperazine | NA |
| Chloroquine 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline | 54-05-7 |
| Hydroxynovaldiamine 2-[(4-aminopentyl)(ethyl)amino]ethan-1-ol | 69559-11-1 |
| Chlortalidone 2-Chloro-5-(1-hydroxy-3-oxo-1- isoindolinyl)benzenesulfonamide | 77-36-1 |
| Chlortalidone EP impurity A Chlorthalidone Chlorosulfobenzoyl Benzoic Acid Impurity | 345930-32-7 |
| Chlortalidone EP impurity B Chlorthalidone USP RC A ; Chlorthalidone Acid ; 2-[3-(Aminosulfonyl)-4-chlorobenzoyl]-benzonic acid | 5270-74-6 |
| Chlortalidone EP impurity C Chlorthalidone Acid Ethyl Ester ; 2-[3-(Aminosulfonyl)-4- chlorobenzoyl]-benzonic acid ethyl ester | 92874-73-2 |
| Chlortalidone EP impurity D Chlorthalidone Ethyl Ether ; O-Ethyl Chlorthalidone ; 2-Chloro- 5[(1RS)-1-ethoxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl] benzene sulfonamide | 1369995-36-7 |
| Chlortalidone EP impurity E Chlorthalidone Deshydroxy Impurity ; 2-Chloro-5-(3-oxo-1- isoindolinyl)benzenesulfonamide | 82875-49-8 |
| Chlortalidone EP impurity G Chlorthalidone Dichloro Impurity ; (3RS)-3-(3,4-Dichlorophenyl)- 3hydroxy-2,3-dihydro-1H-isoindol-1-one | 16289-13-7 |
| Chlortalidone EP impurity H Chlorthalidone Isopropyl Ether ;2-Chloro-5[(1RS)-1-(1- methylethoxy)-3-oxo-2,3-dihydro-1H-isoindol-1-yl] benzenesulfonamide | NA |
| Chlortalidone EP impurity I Chlorthalidone Acid Isopropyl Ester ; 2-[3-(Aminosulfonyl)-4- chlorobenzoyl]-benzonic acid isopropyl ester | NA |
| Chlortalidone Impurity J 3-(4-chlorophenyl)-3-hydroxyisoindolin-1-one | 956-92-3 |
| Chlortalidone Methyl Ether O-Methyl Chlortalidone ; 2-Chloro-5[(1RS)-1-methoxy-3-oxo-2,3- dihydro-1H-isoindol-1-yl]benzene sulfonamide | 6512-76-4 |
| Chloro Intermedate 2-chloro-5-(1-oxoisoindolin-3-yl)benzene-1-sulfonyl chloride | NA |
| 3-(4-Chlorophenyl)-1-isoindolinone 3-(p-Chlorophenyl)-phthalimidine; 3-(4- Chlorophenyl)isoindolinone; 3-(4-Chlorophenyl)-2,3-dihydro-1H- isoindol-1-one | 2224-77-3 |
| 4-(4-Chlorophenyl)-1H-2,3-benzoxazin-1-one | 2224-83-1 |
| Chlorzoxazone 5-Chloro-2-benzoxazolinone;5-Chloro-2-hydroxybenzoxazole | 95-25-0 |
| Chlorzoxazone Related Compound A 2-Amino-4-chlorophenol | 95-85-2 |
| 4-Chlorophenol | 106-48-9 |
| Cefadroxil Monohydrate (6R,7R)-7-[[(2R)-Amino-(4-hydroxyphenyl)acetyl]amino]-3- methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Monohydrate | 66592-87-8 |
| Cefadroxil EP Impurity B 7-AMINODESACETOXYCEPHALOSPORANIC ACID (6R,7R)-7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylic Acid | 22252-43-3 |
| Clopidogrel S-(+)-Clopidogrel Hydrogen Sulfate | 113665-84-2/ 120202-66-6 |
| CHLOPIDOGREL HYDROGEN SULPHATE RACEMATE ( ±)-Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno [3,2-c]pyridin-5-yl)acetate Hydrogen Sulfate | 135046-48-9 90055-48-4 |
| Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3- quinolinecarboxylic Acid | 85721-33-1 |
| Ciprofloxacin EP Impurity A 7-Chloro-1-cyclopropyl-6-fluoro-3-carboxy-1,4-dihydro-4- oxoquinoline; Fluoroquinolonic Acid | 86393-33-1 |
| Ciprofloxacin EP Impurity C Ciprofloxacin Ethylenediamine USP | 103222-12-4 /528851-31-2 |
| Closantel N-[5-chloor-4-[(4-chloorfenyl)-cyanomethyl]-2-methylfenyl]-2- hydroxy-3,5-di-joodbenzamide | 57808-65-8 |
| Closantel EP Impurity A 2-Hydroxy-3,5-diiodobenzoic acid | 133-91-5 |
| Closantel EP Impurity B (2RS)-(4-Amino-2-chloro-5-methylphenyl)(4- chlorophenyl)ethanenitril | 61437-85-2 |
| Closantel EP Impurity C (2RS)-[2-Chloro-4-[(2-hydroxy-3,5-diiodobenzoyl)amino]-5- methylphenyl](4-chlorophenyl)acetic acid | NA |
| Closantel EP Impurity D N-[4-[(1RS)-2-amino-1-(4-chlorophenyl)-2-oxoethyl]-5-chloro-2- methylphenyl]-2-hydroxy-3,5-diiodobenzamide | NA |
| Chlordiazepoxide 7-chloro-2-(methylamino)-5-phenyl-3H-benzo[e][1,4]diazepine 4-oxide | 58-25-3 |
| Chlordiazepoxide EP Impurity A Chlordiazepoxide Related Compound A (7-Chloro-1,3-dihydro-5- phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) | 963-39-3 |
| Clarithromycin 6-O-Methylerythromycin; 6-O-Methylerythromycin A | 81103-11-09 |
| Clonidine 2,6-Dichloro-N-(imidazolidin-2-ylidene)aniline | 4205-90-7 |
| Clonidine EP Impurity A 1-Acetylimidazolidin-2-one | 5391-39-9 |
| Clonidine EP Impurity B Clonidine Related Compound A ; 1-(2-((2,6- dichlorophenyl)amino)-4,5-dihydro-1H-imidazol-1-yl)ethan-1- one | 54707-71-0 |
| Clonidine EP Impurity C 2,6-Dichloroaniline | 608-31-1 |
| Clonidine Impurity B( Inhouse) ethylene diamine mono-p-toluenesulfonic acid salt | 14034-59-4 |
| Dabigatran Etexilate N-[[2-[[[4- [[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methy l]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β- Alanine Ethyl Ester | 211915-06-9 |
| Dabigatran Etexilate Mesylate Impurity A 3-(2-(((4-(((Hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)- 1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5- carboxamido)propanoic Acid | 1408238-37-8 |
| Dabigatran Impurity 1 3-({2-[(4-Carbamimidoyl-phenylamino)-methyl]-1-methyl-1H- benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid ethyl ester | 429658-95-7 |
| Dabigatran Impurity 3 Dabigatran Ethyl Ester Cyano Analog | 211915-84-3 |
| Dabigatran Methylamino Impurity | 212322-56-0 |
| Dabigatran Impurity 4 O-Desethyl Dabigatran Etexilate | 212321-78-3 |
| Dabigatran Impurity 2 N-(4-Cyanophenyl)glycine ; 2-(4-Cyanophenylamino)acetic acid | 42288-26-6 |
| Dabigatran Impurity 8 Hexyl (imino(4-(((1-methyl-5-((3-oxo-3-(pyridin-2- ylamino)propyl)(pyridin-2-yl)carbamoyl)-1H-benzo[d]imidazol-2- thyl)amino)phenyl)methyl)carbamate | 1637238-96-0 |
| Dabigatran Impurity 9 Dabigatran Etexilate Methyl Ester Analog | 211915-00-3 |
| Dabigatran Impurity 10 Dabigatran Etexilate Propanoate | 1304574-20-6 |
| Dabigatran Impurity 6 hexyl (Z)-(amino(4-(((1-methyl-5-(pyridin-2-ylcarbamoyl)-1H- benzo[d]imidazol-2- yl)methyl)amino)phenyl)methylene) carbamate | NA |
| Desethyl Dabigatran Etexilate Carboxamide | 1580491-16-2 |
| Dabigatran Etexilate Isopropyl Ester Analog | 1610758-19-4 |
| Dabigatran Etexilate Dimer | 2101852-25-7 |
| Ethyl 3-(2-Pyridylamino)propionate | 103041-38-9 |
| 4-(Methylamino)-3-nitrobenzoic acid | 41263-74-5 |
| Decitabine 4-amino-1-((2R,4S,5R)-4-hydroxy-5- (hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one | 2353-33-5 |
| Decitabine Related Compound C (2R,3S,5S)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)-2-(((4- chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzo | 1140891-02-6 |
| Desloratadine Desloratadine ; Loratadine USP RC A ; Loratadine EP Impurity D | 100643-71-8 |
| Desloratadine EP Impurity A Desloratadine EP Impurity A ; 11-Fluoro Dihydrodesloratadine | 298220-99-2 |
| Desloratadine EP Impurity C Loratadine ; Ethyl 4-(8-chloro-5,6-dihydro-11H- benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1- piperidinecarboxylate | 79794-75-5 |
| Desloratadine N-Acetyl Impurity Desloratadine N-Acetyl Impurity ; N-Acetyl Desloratadine | 117796-52-8 |
| Desloratadine N-Formyl Impurity Desloratadine USP RC F; Desloratadine N-Formyl Impurity | 117810-61-4 |
| Desloratadine N-Hydroxy Impurity | 1193725-73-3 |
| Desloratadine N-Methyl Impurity Loratadine EP Impurity G ;Loratadine USP RC B | 38092-89-6 |
| Desloratadine Pyridine N-Oxide 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2- b]pyridin-11-ylidene)-piperidine N-oxide | 169253-26-3 |
| Dextromethorphan (9α,13α,14α)-3-Methoxy-17-methylmorphinan3-Methoxy-17 -methyl-9α,13α,14α-morphinan; (+)-3-Methoxy-17- methylmorphinan | 125-71-3 |
| Dextromethorphan Impurity A (+)-3-Methoxy morphinan; (4bR,8aR,9R)-3-Methoxy- 6,7,8,8a,9,10-hexahydro-5H-9,4b- (epiminoethano)phenanthrene | 1531-25-5 |
| Dextromethorphan Impurity B (+)-3-Hydroxy-N-methylmorphinan | 125-73-5 |
| Dextromethorphan N-Oxide Hydrochloride (9α,13α,14α)-3-Methoxy-17-methylmorphinan 17-oxide Hydrochloride | 1177419-85-0 |
| Diazepam 7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin- 2-one | 439-14-5 |
| Diazepam EP Impurity A 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (nordazepam) | 1088-11-5 |
| Diazepam EP Impurity B 2-Chloro-N-(4-chloro-2-benzoylphenyl)-N-methylacetamide | 6021-21-2 |
| Diclazuril – Impurity A/Diclazuril 6-Carboxylic Acid 2-[3,5-Dichloro-4-[(4-chlorophenyl)cyanomethyl]phenyl]-2,3,4, 5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carboxylic Acid | 862243-46-7 |
| 4-Dechloro-4-hydroxy Diclazuril (Impurity B) (+/-)-Benzeneacetonitrile, 4-Dechloro-4-hydroxy Diclazuril | 112206-71-0 |
| Diclazuril 6-Carboxamide (Impurity C) Diclazuril 6-Carboxamide | 1797132-12-7 |
| Descyano Diclazuril Ketone (Impurity D) 2-[3,5-Dichloro-4-(4-chlorobenzoyl)phenyl]-1,2,4-triazine- 3,5(2H,4H)-dione | 133648-81-4 |
| Descyano Diclazuril Ketone (Impurity F) 2-[3,5-Dichloro-4-[(4-chlorophenyl)methyl]phenyl]-1,2,4- triazine | 133648-80-3 |
| Donepezil Hydrochloride (±)-2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-1-indanone hydrochloride | 120011-70-3 |
| Donepezil EP Impurity A Donepezil Desbenzyl Impurity ; 5,6-Dimethoxy-2-(piperidin-4- ylmethyl) indan-1-one | 120014-30-4 |
| Donepezil EP Impurity B 5,6-dimethoxy-2,3-dihydro-1H-inden-1-one | 2107-69-9 |
| Donepezil EP Impurity D Donepezil Pyridine Impurity; 5,6-Dimethoxy-2-(pyridin-4- ylmethyl)indan-1-one | 4803-57-0 |
| Donepezil Related Compound A Donepezil Dehydro Impurity ; (E)-Dehydro Donepezil ; (E)-2-[(1-Benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan- 1-one | 145546-80-1 |
| Donepezil Benzyl Bromide 1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl) methyl]piperidinium bromide | 844694-85-5 |
| Donepezil N-Oxide (RS)-2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-1- indanone N-Oxide | 120013-84-5 |
| Donepezil hydroxy impurity 2,3-Dihydro-2-[hydroxy[1-(phenylmethyl)-4-piperidinyl]methyl]- 5,6-dimethoxy-1H-inden-1-one | 197010-20-1 |
| Dorzolamide (4S,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3- b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride | 130693-82-2 |
| DORZOLAMIDE IMPURITY B (4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H -thieno[2, 3-b]thiopyran-2-sulfonamide 7,7-dioxide Hcl | 120279-37-0 |
| Doxazosin Mesylate 1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-4-[(2RS)-2,3-dihydro -1,4-benzodioxin-2-ylcarbonyl]piperazine methanesulphonate | 77883-43-3 /74191-85-8 |
| Diclofenac Sodium Aceclofenac EP Impurity A ; Sodium 2-[(2,6- dichlorophenyl)amino]phenyl]acetate | 15307-79-6 |
| Diclofenac EP Impurity A Diclofenac USP Related Compound A;Aceclofenac EP Impurity I ; Diclofenac Amide | 15362-40-0 |
| Diclofenac EP Impurity B 2-[(2,6-Dichlorophenyl)amino]benzaldehyde | 22121-58-0 |
| Diclofenac EP Impurity C [2-[(2,6-Dichlorophenyl)amino]phenyl]methanol | 27204-57-5 |
| Diclofenac EP Impurity D 2-[2-[(2-Bromo-6-chlorophenyl) amino]phenyl] acetic acid | 127792-45-4 |
| Diclofenac EP Impurity E 1,3-Dihydro-2H-indol-2-one | 59-48-3 |
| Diclofenac EP Impurity F N-(4-chlorophenyl)-2-(2,6-dichlorophenyl)acetamide | 560075-65-2 |
| Diltiazem HCl (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo- 2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride | 42399-41-7 |
| Diltiazem EP Impurity B (2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro- 1,5-benzothiazepin-3-yl acetate | 87447-47-0 |
| Diltiazem EP Impurity E (2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3- dihydro-1,5-benzothiazepin-4(5H)-one | 42399-49-5 |
| Diltiazem EP Impurity F Desacetyl Diltiazem | 42399-40-6 |
| Duloxetine Hydrochloride (S)-N-Methyl-γ-(1-naphthalenyloxy)-2-thiophenepropanamine Hydrochloride | 136434-34-9 |
| Duloxetine EP Impurity B Duloxetine alcohol (USP) ; (1S)-3-(Methylamino)-1-(thiophen-2- yl)propan-1-ol | 116539-55-0 |
| Duloxetine EP Impurity D α-Napthol (USP) ; Naphthalen-1-ol | 90-15-3 |
| Emtricitabine 4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5- yl]-2-(1H-pyrimidinone | 143491-57-0 |
| Emtricitabine SM 5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2 carboxylic acid 5-methyl-2-(1-methylethyl)cyclohexyl ester | 147126-75-8 |
| Eprosartan (E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2- thienyl methyl)-2-propenoic acid | 133040-01-4 |
| Eprosartan SM 2-Chloro-N-(4-chloro-2-benzoylphenyl)-N-methylacetamide | NA |
| Esomeprazole 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-1H-benzimidazole | 119141-88-7 |
| Esomeprazole EP Impurity A Omeprazole EP Impurity A ; 5-Methoxy-1H-benzimidazole-2- thiol | 37052-78-1 |
| Esomeprazole EP Impurity C Omeprazole EP Impurity C ; 5-methoxy-2-[[(4-methoxy-3,5- dimethylpyridin-2-yl)methyl]sulfanyl]-1H-benzimidazole (ufiprazole) | 73590-85-9 |
| Esomeprazole EP Impurity D Esomeprazole USP Related Compound A ; Esomeprazole USP RC A ; Omeprazole Sulfone | 88546-55-8 |
| “Esomeprazole EP Impurity E Omeprazole EP Impurity E ; Omeprazole N-Oxide ; Omeprazole USP Related Compound E” | 88546-55-8 |
| “Esomeprazole EP Impurity E Omeprazole EP Impurity E ; Omeprazole N-Oxide ; Omeprazole USP Related Compound E” | 176219-04-8 |
| Estradiol (8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17 -decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol | 50-28-2 |
| “Estradiol Related Compound B 6,7-Dehydro Estradiol” | 7291-41-0 |
| “Esketamine Hydrochloride (2S)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride” | 33643-47-9 |
| “Esketamine EP Impurity B (2RS)-2-(2-chlorophenyl)-2-hydroxycyclohexanone” | 1823362-29-3 |
| “Esketamine EP Impurity C (2-chlorophenyl)(1-hydroxycyclopentyl)methanone” | 90717-17-2 |
| Elagolix sodium 4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6- (trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6- dioxo-1 (2H)-pyrimidinyl]-1-phenylethyl]amino]butanoic acid | 834153-87-6 |
| “Elagolix Impurity 1 2-Fluoro-6-(trifluoromethyl)benzonitrile” | 133116-83-3 |
| “Elagolix Impurity 2 2-Fluoro-6-(trifluoromethyl)benzylamine” | 239087-06-0 |
| “Enalaprili Maleate ((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline” | 76095-16-4 |
| “Enalapril Alanyl Proline Enalapril Dipeptide Impurity ;L-Alanyl-L-proline” | 13485-59-1 |
| “Enalapril Impurity 1 Phenylpropanoic acid, Benzenepropionic acid, 3-Phenyl-n- propionic acid” | 501-52-0 |
| “Erythromycin E-Base; E-Mycin; Erythromycin A” | 0114-07-08 |
| “Ethacrynic Acid 2-[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid” | 58-54-8 |
| “Ethacrynic Acid impurity A 4-Butanoyl-2, 3-dichlorophenoxy acetic acid” | 1217-67-0 |
| “Ethacrynic Acid Impurity 4 [2,3-dichloro-4-(2-methylacryloyl)phenoxy]acetic acid” | NA |
| “Febuxostat 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5- carboxylic acid” | 144060-53-7 |
| “Febuxostat Amide Impurity 2-(3-Carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylic acid” | 1239233-86-3 |
| “Febuxostat Dicarboxylic Acid Impurity 2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5- thiazolecarboxylic acid” | 1239233-87-4 |
| “Febuxostat Ethyl Ester Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate” | 160844-75-7 |
| “Febuxostat Isopropyl Ester Isopropyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate” | 1346238-10-5 |
| “Febuxostat Methyl Ester Methyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate” | 923942-34-1 |
| “Febuxostat Impurity 2 ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate” | 161798-03-4 |
| “Febuxostat Impurity 8 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid” | 144060-62-8 |
| Febuxostat Butyl Ester Impurity butyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate | 1619982-02-3 |
| Felbamate (3-carbamoyloxy-2-phenylpropyl) carbamate | 25451-15-4 |
| Felbamate Related Compound A 3- hydroxy-2-phenylpropyl carbamate | 25451-53-0 |
| Felbamate Related Compound B phenethyl carbamate | 6326-19-8 |
| Felbamate Dimer (carbonylbis(oxy))bis(2-phenylpropane-3,1-diyl) dicarbamate | 1796927-91-7 |
| 2-Phenyl-1,3-propanediol | 1570-95-2 |
| 3- Hyrdroxy Felbamate 2-(4-Hydroxyphenyl)-1,3-propanediyl Dicarbamate | 109482-28-2 |
| Fenticonazole Nitrate 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)- 1H-imidazole nitrate | 73151-29-8 |
| Fenticonazole Nitrate EP Impurity A 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethan-1-ol | 24155-42-8 |
| “Fenticonazole Nitrate EP Impurity B 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylsulfinyl)benzyl)oxy)ethyl) -1H-imidazole nitrate” | 80639-95-8 |
| “Fenticonazole Nitrate EP Impurity C 1-(2-(2,4-dichlorophenyl)-2-((4- (phenylsulfonyl)benzyl)oxy)ethyl)-1H-imidazole” | 80676-29-5 |
| “Fenticonazole Nitrate EP Impurity D 3-(2-(2,4-dichlorophenyl)-2-hydroxyethyl)-1-(4- (phenylthio)benzyl)-1H-imidazol-3-ium nitrate” | 1313397-05-5 |
| “Fenticonazole Nitrate EP Impurity E 3-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)-1- (4-(phenylthio)benzyl)-1H-imidazol-3-ium Hydrochloride” | 756429-44-4 |
| “4-phenyl thio benzyl chloride (4-(chloromethyl)phenyl)(phenyl)sulfane” | 1208-87-3 |
| “Fexofenadine (R)-2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1- yl)butyl)phenyl)-2-methylpropanoic acid” | 83799-24-0 |
| “Fexofenadine EP Impurity A Fexofenadine USP related compound A” | 76811-98-8 |
| “Fexofenadine EP Impurity B 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl )butyl)phenyl)-2-methylpropanoic acid” | 479035-75-1 |
| “Fexofenadine EP Impurity C Decarboxylated degradant” | 185066-37-9 |
| “Fexofenadine EP Impurity D methyl -2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl) butyl)phenyl)-2-methylpropanoate” | 154825-96-4 |
| “Fexofenadine EP Impurity E diphenyl(piperidin-4-yl)methanol” | 115-46-8 |
| “Fexofenadine Impurity 1 methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate” | 154477-54-0 |
| “Flecainide acetate N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2- trifluoroethoxy)benzamide acetate” | 54143-56-5 |
| “Flecainide EP Impurity B (RS)-(piperidin-2-yl)methanamine” | 22990-77-8 |
| “Fosfomycin Tromethamine 2-amino-2-(hydroxymethyl)propane-1,3-diol ((2R,3S)-3- methyloxiran-2-yl) phosphonate” | 78964-85-9 |
| “Fosfomycin Trometamol EP Impurity A (1,2-dihydroxypropyl)phosphonic acid” | 84954-80-3 |
| “Fosfomycin Trometamol EP Impurity C 2-amino-3-hydroxy-2-(hydroxymethyl)propyl dihydrogen phosphate” | 23001-39-0 |
| “Glimepiride 1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea” | 93479-97-1 |
| “Glimepiride EP Impurity B USP Glimepiride Related Compound B ; Glimepiride Sulfonamide” | 119018-29-0 |
| “Glimepiride EP Impurity C Glimepiride Ester” | 119018-30-3 |
| “Gabapentin 1-(Aminomethyl)cyclohexaneacetic acid” | 60142-96-3 |
| “Gabapentin EP Impurity A Gabapentin USP Related Compound A ; Gabapentin Lactam ; 3-Azaspiro-[4,5]decan-3-one” | 64744-50-9 |
| “Gabapentin EP Impurity B Gabapentin USP Related Compound B;(1- Cyanocyclohexyl)acetic acid” | 133481-09-1 |
| “Gabapentin EP Impurity E Gabapentin USP Related Compound E ; Gabapentin Diacid ; 1-(carboxymethyl)cyclohexanecarboxylic acid” | 67950-95-2 |
| “Guaifenesin Ranolazine Related Compound 2;3-(2- methoxyphenoxy)propane-1,2-diol” | 93-14-1 |
| “Guaifenesin EP Impurity A 2-methoxyphenol” | 90-05-1 |
| “Guaifenesin EP Impurity D Dianisylglycerol ; 1,3-bis(2-methoxyphenoxy)propan-2-ol” | 16929-60-5 |
| “Guaifenesin Impurity 1 2-((2-methoxyphenoxy)methyl)oxirane” | 2210-74-4 |
| “Gliclazide 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4- methylphenyl)sulfonyl]urea” | 21187-98-4 |
| “Gliclazide EP Impurity A Gliclazide BP Impurity A ; 4-Methylbenzenesulfonamide” | 70-55-3 |
| Gliclazide EP Impurity B Gliclazide BP ImpurityB;2-Nitroso- octahydrocyclopenta[c]pyrrole | 54786-86-6 |
| “Gliclazide EP Impurity C Gliclazide BP Impurity C ; Ethyl [(4-methylphenyl)sulfonyl]- carbamate” | 5577-13-9 |
| “Gliclazide EP Impurity D Gliclazide BP Impurity D;N-[(4- Methylphenyl)sulfonylhexahydrocyclopenta[c] pyrrol-2(1H)-carboxamide” | 1136426-19-1 |
| “Gliclazide Impurity 1 hexahydrocyclopenta[c]pyrrol-2(1H)-amine hydrochloride” | 58108-05-07 |
| “Glipizide N-[2-[4[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5- methylpyrazinecarboxamide” | 9094-61-9 |
| “Glipizide EP Impurity A Glipizide Related Compound A ; [2-(4-Sulphamoylphenyl) ethyl] 5-methyl-pyrazine-2- carboxamide ;” | 33288-71-0 |
| “Glipizide EP Impurity B cyclohexanamine” | 108-91-8 |
| “Glipizide EP Impurity G methyl ((4-(2-(5-methylpyrazine-2- carboxamido)ethyl)phenyl)sulfonyl)carbamate” | 33288-74-3 |
| “Guanine 2-amino-9H-purin-6(1H)-one” | 73-40-5 |
| “Haloperidol 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4- fluorophenyl)-1-butanone” | 52-86-8 |
| “Haloperidol EP Impurity A 1-(4-fluorophenyl)-4-(4-hydroxy-4-phenylpiperidin-1-yl)butan-1- one ; Dechlorohaloperidol” | 04-12-3109 |
| “Haloperidol EP Impurity B Haloperidol Related Compound B” | 1391052-53-1 |
| “Haloperidol EP Impurity D Haloperidol USP Related Compound A” | 67987-08-0 |
| “Haloperidol EP Impurity H Haloperidol N-Oxide” | 148406-51-3 |
| “Haloperidol Impurity 8 Chloro-fluoro-butyrophenone ; 4-chloro-1-(4- fluorophenyl)butan-1-one; 3-(4-Fluorophenylcarbonyl)-1- chloropropane” | 3874-54-2 |
| “Haloperidol Impurity 9 4-(4-chlorophenyl)-4-hydroxypiperidine ; Chlorophenyl hydroxypiperidine” | 39512-49-7 |
| “trans-Haloperidol N-Oxide 4-[trans-4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1- (4-fluorophenyl)-1-butanone” | 150214-93-0 |
| “cis-Haloperidol N-Oxide 4-[cis-4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4- fluorophenyl)-1-butanone” | 150214-94-1 |
| “Hydrochlorothiazide 6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide” | 58-93-5 |
| “Hydrochlorothiazide EP Impurity A 3,4-Dehydro Hydrochlorothiazide ; Chlorothiazide” | 58-94-6 |
| “Hydrochlorothiazide EP Impurity B Hydrochlorothiazide USP Related Compound A” | 121-30-2 |
| “Hydroxychloroquine Sulfate 2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol Sulfate” | 747-36-4 |
| “Hydroxychloroquine EP Impurity G 4,7-Dichlrorquinoline” | 86-98-6 |
| “Irbesartan 2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3- diazaspiro[4.4]non-1-en-4-one” | 138402-11-6 |
| “Irbesartan EP Impurity A Irbesartan USP Related Compound A” | 748812-53-5 |
| “Irbesartan Lactam Impurity 2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one Hydrochloride” | 151257-01-1 |
| “Irbesartan Bromo Nitrile Impurity 4′-(Bromomethyl)biphenyl-2-carbonitrile” | 114772-54-2 |
| “Irbesartan Cyano Impurity 4′-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3- yl)methyl]biphenyl-2-carbonitrile” | 138401-24-8 |
| “Irbesartan Dibromomethyl Impurity 4′-(Dibromomethyl)biphenyl-2-carbonitrile” | 209911-63-7 |
| “Irbesartan Hydroxy Impurity Candesartan Hydroxy Impurity ; p-(o-1H-Tetrazol-5- ylphenyl)benzyl alcohol” | 160514-13-6 |
| “Irbesartan Bromo N2-Trityl Impurity 5-(4′-Bromomethyl-1,1′-biphenyl-2-yl)-1-triphenylmethyl-1H- tetrazole” | 124750-51-2 |
| “Irbesartan Impurity C 2-[4-(Hydroxymethyl)phenyl]benzonitrile; 4-(Hydroxymethyl)-2′- cyanobiphenyl” | 154709-19-0 |
| “Ivabradine Hydrochloride (S)-3-(3-(((4,5-dimethoxy-1,2 dihydrocyclobutabenzen1yl)methyl)(methyl)amino)propyl)-7,8- dimethoxy-4,5-dihydro-1Hbenzo[d] azepin-2(3H)-one hydrochloride” | 148849-67-6 |
| 7,8-dimethoxy-1,3-dihydro-2H-benzo[d]azepin-2-one | 73942-87-7 |
| “Ivabradine chloro Impurity 3-(3-chloropropy)-7,8-dimethoxy-1,3-dihydro-2H- benzo[d]azepin-2-one” | 85175-59-3 |
| “Ivabradine Iodo Impurity 6-3-(3-iodopropyl)-7,8-dimethoxy-1,3-dihydro-2H- benzo[d]azepin-2-one” | 148870-57-9 |
| “Ivabradine Impurity 1 3-(3-chloropropyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H- benzo[d]azepin-2-one” | 85175-65-1 |
| “Ivabradine Impurity 3 1-bromo-3-chloropropane” | 109-70-6 |
| “Ivabradine Impurity 14 3,3′-(propane-1,3-diyl)bis(7,8-dimethoxy-1,3,4,5-tetrahydro-2H- benzo[d]azepin-2-one)” | NA |
| “Isosorbide 1,4:3,6-Dianhydro-D-glucitol” | 652-67-5 |
| “Isosorbide Mononitrate 1,4:3,6-Dianhydro-D-glucitol 5-Nitrate,Isosorbide 5- Mononitrate” | 16051-77-7 |
| “Isosorbide Mononitrate EP Impurity A Isosorbide Dinitrate” | 87-33-2 |
| “Ketoprofen 2-(3-benzoylphenyl)propanoic acid” | 22071-15-4 |
| ketoprofen EP impurity A Ketoprofen Related Compound D; 1-(3-benzoylphenyl)ethan-1-one | 66067-44-5 |
| “ketoprofen EP impurity C 3-(1-carboxyethyl)benzoic acid” | 68432-95-1 |
| “ketoprofen EP impurity D 2-(3-(4-methylbenzoyl)phenyl)propanoic acid” | 107257-20-5 |
| “ketoprofen EP impurity E 2-(3-benzoylphenyl)propanamide” | 59512-16-2 |
| “ketoprofen EP impurity F 2-(3-benzoylphenyl)propanenitrile” | 42872-30-0 |
| “ketoprofen EP impurity G 3-(1-cyanoethyl)benzoic acid” | 5537-71-3 |
| “Ketamine Hydrochloride (2RS)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride.” | 1867-66-9 |
| “Esketamine EP Impurity B (2RS)-2-(2-chlorophenyl)-2-hydroxycyclohexanone” | 1823362-29-3 |
| “Esketamine EP Impurity C (2-chlorophenyl)(1-hydroxycyclopentyl)methanone” | 90717-17-2 |
| “Labetalol 2-hydroxy-5-((S)-1-hydroxy-2-(((S)-4-phenylbutan-2- yl)amino)ethyl) benzamide hydrochloride” | 32780-64-6 |
| Labetalol EP Impurity A | NA |
| 2-hydroxy-5-((S)-1-hydroxy-2-(((S)-4-phenylbutan-2- | 1391051-99-2 |
| yl)amino)ethyl)benzoic acid | NA |
| Labetalol EP Impurity B | NA |
| “methyl 2-hydroxy-5-((S)-1-hydroxy-2-(((S)-4-phenylbutan-2-yl) amino)ethyl)benzoate” | 802620-01-5 |
| Labetalol EP Impurity C 5-(2-(benzylamino)-1-hydroxyethyl)-2-hydroxybenzamide | NA |
| Labetalol EP Impurity D 5-[(1RS)-2-amino-1-hydroxyethyl]-2-hydroxybenzamide | NA |
| Labetalol EP Impurity G 3-bromo-2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzamide. | NA |
| Lacidipine Diethyl 4-{o-[(E)-2-tert-butoxycarbonylethenyl]phenyl}-2,6- dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 103890-78-4 |
| cis Lacidipine (Z)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-1,4- dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester | 103890-79-5 |
| Lacosamide (2R)-2-(Acetylamino)-3-methoxy-N- (phenylmethyl)propanamide | 181289-15-6 |
| Progesterone | NA |
| Progesterone EP Impurity B | NA |
| “Prucalopride Succinate 4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3 -dihydrobenzofuran-7-carboxamide succinate” | 179474-85-2 |
| “Prucalopride impurity A 4-amino-5-chloro2,3-dihydro-N(piperidin4-yl) benzofuran – 7carboxamide” | 137211-64-4 |
| “Prucalopride impurity B 4-amino-5-chloro-2,3dihydro-1-benzofuran7-carboxamide” | 182808-16-8 |
| “Prucalopride impurity D Methyl 4-amino-5chloro-2,3dihydrobenzofuran7-carboxylate” | 182808-04-4 |
| “Quetiapine Fumarate 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1- piperazinyl)ethoxy]ethanol hemifumarate” | 111974-72-2 |
| “Quetiapine EP Impurity A 2-[2-(4-Dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]- ethyl acetate” | 844639-07-2 |
| “Quetiapine EP Impurity B Quetiapine USP Related Compound B ; Dibenzo[b,f][1,4]thiazepine-11-yl-piperazine dihydrochloride” | 111974-74-4 |
| “Quetiapine EP Impurity D Quetiapine Dimer Impurity ; Quetiapine Bis(dibenzothiazepinyl) piperazine Impurity (USP)” | NA |
| “Quetiapine EP Impurity G Quetiapine USP Related Compound G ; Dibenzo[b,f][1,4]thiazepine-11(10-H)-one” | 07-07-3159 |
| “Quetiapine EP Impurity H Quetiapine USP Related Compound B ; Dibenzo[b,f][1,4]thiazepine-11-yl-piperazine dihydrochloride” | 1076199-40-0 |
| “Quetiapine EP Impurity I HCl Salt Quetiapine Desethoxy Impurity (USP) ; Quetiapine Alcohol Impurity” | 329218-14-6 |
| Quetiapine DBTC Impurity Dibenzo[b,f][1,4]thiazepine-11-yl-chloride ; 11-Chloro- dibenzo[b,f][1,4] thiazepine | 13745-86-3 |
| “Quetiapine DBTP N-Methyl Impurity 11-(4-Methylpiperazin-1-yl)-dibenzo[b,f][1,4]thiazepine” | 09-09-1977 |
| “Rabeprazole Sodium Sodium 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2- yl]methylsulfinyl ]benzoimidazole” | 117976-90-6 |
| “Rabeprazole EP Impurity A Rabeprazole USP Related Compound D ; Rabeprazole Sulfone ;” | 117976-47-3 |
| “Rabeprazole EP Impurity B Rabeprazole USP Related Compound E ; Rabeprazole Sulfide ;” | 117977-21-6 |
| “Rabeprazole EP Impurity D Rabeprazole USP Related Compound B , Rabeprazole N-Oxide” | 924663-38-7 |
| “Rabeprazole EP Impurity F Rabeprazole USP Related Compound C ; Lansoprazole EP Impurity E” | 583-39-1 |
| “Rabeprazole EP Impurity I Rabeprazole Sulfone N-Oxidele” | 924663-37-6 |
| “Rabeprazole EP Impurity K Lansoprazole EP Impurity D ; 2-Hydroxybenzimidazole” | 615-16-7 |
| “Rabeprazole Sulfide N-Oxide Rabeprazole Sulfide N-Oxide ;” | 924663-40-1 |
| “Rabeprazole 2-Chloromethyl Impurity 2-Chloromethyl-3-methyl-4-(3-methoxypropoxy)pyridine hydrochloride” | 153259-31-5 |
| “Ranolazine N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2- methoxyphenoxy)propyl]-1-piperazineacetamide” | 95635-55-5 |
| “Ranolazine Related Compound A 2-[(2-Methoxyphenoxy)methyl]oxirane” | 2210-74-4 |
| “Ranolazine Related Compound B Ranolazine Desmethoxy Impurity ; N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3- phenoxypropyl)piperazin-1-yl)acetamide” | 755711-09-2 |
| “Ranolazine Related Compound C 1-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine” | 5294-61-1 |
| “Ranolazine Related Compound D N,N’-bis(2,6-Dimethylphenyl)-1,4-piperazinediacetamide” | 380204-72-8 |
| “Ranolazine Related Compound 2 Guaifenesin ; 3-(2-methoxyphenoxy)propane-1,2-diol” | 93-14-1 |
| “Ranolazine Related Compound 4 1-(2-methoxyphenoxy)-2,3- epoxy propane” | 2210-74-4 |
| “Ranolazine impurity C 1-(2-methoxyphenoxy)-3-(piperazin-1-yl)propan-2-ol” | 162712-35-8 |
| “1-chloro-3-(2-methoxyphenoxy)propan-2-ol 1-chloro-3-(2-methoxyphenoxy)propan-2-ol” | 25772-81-0 |
| “Ranolazine Dimer Impurity α,α’-Bis[(2-Methoxyphenoxy)methyl]-1,4-piperazinediethanol” | 333749-57-8 |
| “Ranolazine N-Oxide 1-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-4-(2-hydroxy-3-(2 methoxyphenoxy)propyl)piperazine 1-oxide; Ranolazine Mono- N-oxide” | NA |
| “m-Ranolazine N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(3-methoxyphenoxy) propyl)piperazin-1-yl)acetamide Hydrochloride” | NA |
| “Dianisylglycerol 1,3-Bis(2-methoxyphenoxy)-2-propanol , Guaifenesin EP Impurity D” | 16929-60-5 |
| “N-(2,6-Dimethylphenyl)-2-hydroxyacetamide cetamide, N-(2,6-dimethylphenyl)-2-hydroxy” | 29183-14-0 |
| “1,3-bis(2-methoxyphenoxy)propan-2-ol 1,3-bis(2-methoxyphenoxy)propan-2-ol” | NA |
| “Rivaroxaban 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5- oxazolidinyl] methyl]-2-thiophenecarboxamide” | 366789-02-8 |
| Roxithromycin | 80214-83-1 |
| “Rosuvastatin Calcium (3R,5S,6E)-7-{4-(4-Fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5- dihydroxyhept-6-enoic acid calcium salt” | 147098-20-2 |
| “Rosuvastatin EP Impurity D N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)- tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2- pyrimidinyl]-N-methyl-methanesulfonamide” | 503610-43-3 |
| ROSUVASTATIN IMPURITY-K | 1422954-12-8 |
| ROSUVASTATIN IMPURITY-M | 847849-66-5 |
| “Sitagliptin (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5- trifluorophenyl) butan-1-one hydrochloride” | 486459-71-6 |
| “Sitagliptin EP Impurity A (S)-SitagliptinIsomer ; (S)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl) butan-2-amine ;” | 823817-55-6 |
| “Sitagliptin FP Impurity E (3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid” | “936630-57-8/ 1204818-19-8 (Hcl salt)” |
| “Sitagliptin Triazole Hydrochloride Sitagliptin Impurity 20 HCl; 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3- a]pyrazine hydrochloride” | 762240-92-6 |
| “Sitagliptin Ketoamide Impurity Sitagliptin dioxo impurity; (2Z)-4-Oxo-4-[3-(trifluoroMethyl)-5,6-dihydro-[1,2,4] triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan- 2-one ;” | 64667-65-4 |
| “Sitagliptin N-Acetyl Impurity Sitagliptin impurity D; N-Acetyl Sitagliptin ; 7-[(3R)-3-[(N-Acetyl)amino]-1-oxo-4-(2,4,5- trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)- 1,2,4-triazolo[ 4,3-a]pyrazine” | 1379666-94-0 |
| “(S)-Sitagliptin N-Boc-Acid Impurity (S)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5- trifluorophenyl)butanoic acid” | 922178-94-7 |
| (R)-Sitagliptin N-Boc-Methyl-Ester Impurity methyl (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5- trifluorophenyl) butanoate | 881995-73-9 |
| “(R)-Sitagliptin Methyl-Ester Impurity methyl (R)-3-amino-4-(2,4,5-trifluorophenyl)butanoate” | 881995-69-3 |
| “Sitagliptin Impurity 19 (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5- trifluorophenyl)butanoic acid” | 486460-00-8 |
| “Sitagliptin Impurity 18 tert-butyl (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5- trifluorophenyl)butan-2-yl)carbamate” | 486460-23-5 |
| “Sitagliptin Impurity 6 (R)-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2- yl)formamide” | NA |
| “4-Methyl L-Aspartate Hydrochloride 4-Methyl L-Aspartate Hydrochloride” | 16856-13-6 |
| “D-Aspartic Acid 4-Methyl Ester Hydrochloride D-Aspartic Acid 4-Methyl Ester Hydrochloride” | 22728-89-8 |
| “2,4,5-Trifluorophenylacetic Acid 2,4,5-Trifluorophenylacetic Acid” | 209995-38-0 |
| “Tadalafil (6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2- methylpyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione; Cialis;” | 171596-29-5 |
| “Telmisartan 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl- 1H-1,3 -benzodiazol-1-yl] methyl}phenyl)benzoic acid” | 144701-48-4 |
| “Telmisartan EP Impurity A Telmisartan USP Related Compound A” | 152628-02-9 |
| “Telmisartan EP Impurity B Telmisartan USP Related Compound B ; Telmisartan Isomer” | 1026353-20-7 |
| “Telmisartan EP Impurity C Telmisartan t-Butyl Ester” | 144702-26-1 |
| “Telmisartan EP Impurity F Telmisartan Amide” | 915124-86-6 |
| “Telmisartan Methyl Ester 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl) -2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid methyl ester” | 528560-93-2 |
| “Telmisartan Ethyl Ester 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl -1H-1,3-benzodiazol-1-yl] methyl}phenyl)benzoic acid ethyl ester” | 528560-94-3 |
| “Telmisartan Bromo Nitrile Impurity 4′-(Bromomethyl)-[1,1′-biphenyl]-2-carbonitrile ; 2-(4- Bromomethylphenyl) benzonitrile” | 114772-54-2 |
| “Teriflunomide (E)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2- enamide” | 214782-56-6 |
| “Teriflunomide Impurity 1 3-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide” | 208401-20-1 |
| “Teriflunomide Impurity 3 4-amino-N-(4-(trifluoromethyl)phenyl)benzamide” | 1011244-72-6 |
| “Teriflunomide Impurity 4 1-ethoxy-4-(trifluoromethyl)benzene” | 2366-92-9 |
| Teriflunomide Impurity 16 N-(4-(trifluoromethyl)phenyl)acetamide | 349-97-3 |
| Teriflunomide Impurity 18 2-cyano-N-(4-(trifluoromethyl)phenyl)acetamide | 24522-30-3 |
| Teriflunomide Impurity12 Leflunomide ; 5-Methyl-N-[4-(trifluoromethyl)phenyl]isoxazole- 4-carboxamide | 75706-12-6 |
| Teriflunomide ortho isomer | NA |
| Teriflunomide Meta isomer | NA |
| Tetracycline (4S,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro- 3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene- 2-carboxamide | 60-54-8 |
| Anhydro tetracycline impurity (4S,4aS,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-Hexahydro- 3,10,11,12a-Tetrahydroxy-6-Methyl-1,12-Dioxotetracene-2- Carboxamide | NA |
| Thiamazole 1-Methyl-3H-imidazole-2-thione | 60-56-0 |
| Thiamazole EP Impurity B 1-Methyl-1H-imidazole; N-Methylimidazole | 616-47-7 |
| “Tirofiban (S)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4- yl)butoxy)phenyl)propanoic acid” | 144494-65-5 |
| “Tirofiban Impurity A L-N-Butylsulfonyl-p-hydroxyphenylalanine,” | 149490-60-8 |
| “TIROFIBAN IMPURITY B 4-(4-Chlorobutyl)pyridine hydrochloride” | 149463-65-0 |
| Tramadol | 36282-47-0 |
| “Tramadol EP Impurity A Tramadol Related Compound A” | “152538-36- 8/36282-47-0” |
| “Tramadol EP Impurity B 1-(3′-methoxy-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)-N,N- dimethylmethanamine hydrochloride” | 66170-32-9 |
| “Tramadol EP Impurity C 1-(3′-methoxy-2,3,4,5-tetrahydro-[1,1′-biphenyl]-2-yl)-N,N- dimethylmethanamine hydrochloride” | 66170-31-8 |
| “Tramadol EP Impurity D 3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol hydrochloride” | 148218-19-3 |
| “Tramadol EP Impurity E Tramadol Related Compound B ; 2-((dimethylamino)methyl)cyclohexan-1-one hydrochloride” | 42036-65-7 |
| “Tramadol N-Oxide 1-((1S,2S)-2-hydroxy-2-(3-methoxyphenyl)cyclohexyl)- N,N-dimethylmethanamine oxide” | 147441-56-3 |
| “Tramadol EP Impurity A ( Free Base) (±)-trans-2-[(Dimethylamino)methyl]-1-(3- methoxyphenyl)cyclohexanol” | NA |
| “Tropicamide (2RS)-N-Ethyl-3-hydroxy-2-phenyl-N-(pyridin-4- ylmethyl)propanamide” | 1508-75-4 |
| “Tropicamide EP Impurity A, Tropicamide related compound A, N-(pyridin-4- ylmethyl)ethanamine” | 33403-97-3 |
| “Tropicamide EP Impurity B Tropicamide related compound B” | 57322-50-6 |
| “Tropicamide EP Impurity C Tropicamide related compound C” | 552-63-6 |
| “Tropicamide EP Impurity D Tropicamide related compound D, phenylacetic acid” | 103-82-2 |
| “Teneligliptin HBr [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]- 2-pyrrolidinyl]-3-thiazolidinylmethanone HBr” | 906093-29-6 |
| “Tenegliptin impurity A 1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine” | 401566-79-8 |
| “Tenteligliptin impurity B tert-butyl (2S,4S)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5- yl)piperazin-1-yl)-2-(thiazolidine-3-carbonyl)pyrrolidine-1- carboxylate” | 401566-80-1 |
| “Tenteligliptin impurity C (2S)-tert-butyl4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine- 1-carboxylate” | NA |
| “Tenteligliptin impurity 1 (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester” | 401564-36-1 |
| “Teneligliptin (2R,4R)-Isomer {(2R4R)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-l- yl]pyrrolidine-2-yl}( 1.3-thiazolidine-3-yl) methanone hemipentahydrobromide hydrate” | “1404559-17-6 (Free Base)” |
| “Tenteligliptin impurity 2 (2R,4S)-1-(tert-butoxycarbonyl)-4-hydroxypyrrolidine-2- carboxylic acid” | 147266-92-0 |
| “Tenteligliptin impurity 3 3-[(2R,4S)-1-tert-Butoxycarbonyl-4-hydroxy-2- pyrrolidinylcarbonyl]-1,3-thiazolidine” | NA |
| “Tenteligliptin impurity 4 (2R)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester” | NA |
| Tolterodine | 124937-51-5 |
| Tolterodine monoisopropyl analog | 480432-14-2 |
| “Valsartan (S)-N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine” | 137862-53-4 |
| “Valsartan EP Impurity C Valsartan related compound B ; Valsartan N-Butyryl Analog” | 952652-79-8 |
| “N-Nitrosodimethylamine N-Methyl-N-nitrosomethanamine; DMN; DMNA;” | 62-75-9 |
| “N- nitrosodiethylamine (NDEA). N-Ethyl-N-nitrosoethanamine; DEN; DENA; Diethylnitrosamide” | 55-18-5 |
| “Nitroso-N-methyl-4-aminobutyric acid (NMBA) 4-(Methylnitrosoamino)butanoic Acid; N-Methyl-N-(3- carboxypropyl)nitrosamine” | 61445-55-4 |
| “Valganciclovir Hydrochloride L-Valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]- 3-hydroxy propyl ester hydrochloride” | 175865-59-5 |
| “Valaciclovir EP Impurity A/ Valganciclovir related compound B Valganciclovir related compound B, A ciclovir EP Impurity B ; Guanine” | 73-40-5 |
| Diacetylguanine | 3056-33-5 |
| “Venlafaxine HCl 1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride” | 99300-78-4 |
| “Venlafaxine EP Impurity C N,N-Didesmethyl Venlafaxine Hydrochloride” | 130198-05-9 |
| “Venlafaxine EP Impurity D Venlafaxine USP Related Compound A” | 149289-30-5 |
| “Venlafaxine EP Impurity E (5RS)-5-(4-methoxyphenyl)-3-methyl-1-oxa-3- azaspiro[5.5]undecane” | 93413-70-8 |
| “Vildagliptin (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- 2-pyrrolidinecarbonitrile” | 274901-16-5 |
| “Vildagliptin Chloroacetyl Nitrile (R)-Isomer Vildagliptin Chloroacetyl Nitrile (R)-Isomer” | 565452-98-4 |
| “Vildagliptin Chloroacetyl Nitrile (S)-Isomer (2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile ; Vildagliptin Impurity 14” | 207557-35-5 |
| “Vildagliptin Amino Alcohol Impurity 1-Amino-3-adamantanol ; Vildagliptin Impurity 15” | 702-82-9 |
| “Vildagliptin Carboxamide Impurity (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- 2-pyrrolidine carboxamide ; Vildagliptin Impurity 16” | 565453-39-6 |
| “Vildagliptin Dimer Impurity (2S,2’S)-1,1′-(2,2′-(((1r,3R,5R,7S)-3-hydroxyadamantan-1- yl)azanediyl)bis(acetyl))bis(pyrrolidine-2-carbonitrile)” | 1036959-23-5 |
| “(R)-Vildagliptin (R)-1-(((1r,3S,5R,7S)-3-hydroxyadamantan-1- yl)glycyl)pyrrolidine-2-carbonitrile” | 1036959-27-9 |
| “Vildagliptin Chloroacetyl Amide (S)-Isomer (S)-1-(2-chloroacetyl)pyrrolidine-2-carboxamide” | 214398-99-9 |
| “Vildagliptin Chloroacetyl Amide (R)-Isomer (R)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide” | 1211679-98-9 |
| “Vildagliptin Carboxylic Acid Impurity (2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- 2-pyrrolidine carboxylic acid” | NA |
| (2S)-1-(AMINOACETYL) PYRROLIDINE -2-CARBONITRILE | NA |
| (S)-Hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione | 3705-27-9 |
| “Vortioxetine 1-[2-[(2,4-Dimethylphenyl)thio]phenyl]piperazine” | 508233-74-7 |
| Vortioxetine Sulfoxide | 1429908-35-9 |
| “Vortioxetine Impurity 31 2,4-Xylenethiol; 2,4-Dimethylbenzenethiol; 2,4- Dimethylthiopheno” | 13616-82-5 |
| “Warfarin 2-Oxo-3-[(1RS)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-4-ol” | 81-81-2 |
| “Zolpidem N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3- acetamide” | 82626-48-0 |
| “Zolpidem Tartrate EP Impurity B 2-[2-(3-bromo-4-methylphenyl)-6-methylimidazo[1,2-a]pyridin- 3-yl]-N,N-dimethylacetamide” | NA |
| N,N-Dimethylprop-2-ynamide | 2682-34-0 |
| “Zonisamide 1,2-Benzisoxazole-3-methanesulfonamide” | 68291-97-4 |
| “Zonisamide Related Compound A (1,2-benzisoxazole-3-methanesulfonic acid sodium salt” | 73101-64-1 |
| “Zonisamide Related Compound C N,N-Dimethyl Formimidamide ; (E)-N’-((benzo[d]isoxazol-3-ylmethyl)sulfonyl)-N,N- dimethylformimidamide” | 1217201-89-2 |
| “N-Methyl Zonisamide N-Methyl-1,2-benzisoxazole-3-methanesulfonamide” | 68292-02-04 |
| 1,2-Benzisoxazol-3-ylacetic Acid | 4865-84-3 |
| Azithromycin Impurity A | 76801-85-9 |
| Azithromycin Impurity E | 612069-27-9 |
| Azithromycin Impurity F | 612069-28-0 |
| Azithromycin Impurity G | 612069-31-5 |
| Azithromycin Impurity H | 612069-30-4 |
| Azithromycin Impurity I | 172617-84-4 |
| Azithromycin Impurity J | 117693-41-1 |
| Azithromycin Impurity L | 90503-06-3 |
| Azithromycin Impurity M | 765927-71-7 |
| Azithromycin Impurity N | 612069-25-7 |
| Azithromycin Impurity Q | 2095879-65-3 |
| Azithromycin Impurity R | 99290-97-8 |
| Azithromycin Impurity S | 161193-44-8 |
| Azithromycin Impurity P | NA |
| Erythromycin A oxime | 111321-02-9 |
| Azithromycin Impurity C | 620169-47-3 |
| Azithromycin Impurity D | 612069-26-8 |
| Azithromycin Impurity O | 763924-54-5 |
| Azithromycin Impurity K | 612534-95-9 |
| Azithromycin Impurity B | 307974-61-4 |
| Erythromycin EP Impurity B | 992-62-1 |
| Erythromycin EP Impurity B | 992-62-1 |
| Erythromycin EP Impurity D | 23893-13-2 |
| Erythromycin EP Impurity E | 33396-29-1 |
| Erythromycin EP Impurity F | 105882-69-7 |
| Erythromycin EP Impurity Ethyl succinate G | NA |
| Erythromycin EP Impurity H | 992-65-4 |
| Erythromycin EP Impurity I | 546-57-6 |
| Erythromycin EP Impurity L | 127955-44-6 |
| Erythromycin Impurity A | 82230-93-1 |
| Erythromycin Impurity C | 41451-91-6 |
| Erythromycin Impurity N | 992-65-4 |
| Erythromycin Impurity M | 616234-56-1 |
| Erythromycin Ethyl Fumarate | 122293-08-7 |
| Fusidic Acid EP Impurity A | 80445-74-5 |
| Fusidic Acid EP Impurity C | NA |
| Fusidic Acid EP Impurity D | NA |
| Fusidic Acid EP Impurity G | 4680-37-9 |
| Fusidic Acid EP Impurity H | 16711-91-4 |
| Fusidic Acid EP Impurity I | 5951-83-7 |
| Fusidic Acid EP Impurity J | 13011-12-6 |
| Fusidic Acid EP Impurity K | 4701-54-6 |
| Fusidic Acid EP Impurity L | 74048-41-2 |
| Fusidic Acid EP Impurity M | 1013937-16-0 |
| Fusidic Acid EP Impurity O | 55601-53-1 |
| Valsartan Impurity 1 | 124806-66-2 |
| Valsartan EP Impurity A | 137862-87-4 |
| Valsartan EP Impurity B | 137863-20-8 |
| Valsartan EP Impurity C | 952652-79-8 |
| Valsartan Related compound E | 137863-17-3 |
| Valsartan Ethyl Ester Impurity | 1111177-30-0 |
| Valsartan Isopropyl Ester Impurity | 1245820-09-0 |
| Olanzapine Lactam | 1017241-34-7 |
| Olanzapine Thiolactam | 1017241-36-9 |
| Clarithromycin Impurity B | 299409-85-1 |
| Clarithromycin Impurity C | 127253-06-9 |
| Clarithromycin Impurity D | 101666-68-6 |
| Clarithromycin Impurity E | 81103-14-2 |
| Clarithromycin Impurity G | 127182-44-9 |
| Clarithromycin Impurity H | 127140-69-6 |
| Clarithromycin Impurity I | 118058-74-5 |
| Clarithromycin Impurity J | 13127-18-9 |
| Clarithromycin Impurity K | 127157-35-1 |
| Clarithromycin Impurity L | 127253-05-8 |
| Clarithromycin Impurity M | 127182-43-8 |
| Clarithromycin Impurity O | 127252-80-6 |
| Clarithromycin Impurity P | 123967-58-8 |
| Clarithromycin Impurity Q | 118074-07-0 |
| Clarithromycin Impurity R | 992-62-1 |
| Roxithromycin Impurity B | 214902-82-6 |
| Roxithromycin Impurity D | 134931-00-3 |
| Roxithromycin Impurity F | 118267-18-8 |
| Roxithromycin Impurity G | 425365-64-6 |
216, Vardhaman Complex, 10, LBS Marg, Vikhroli West, Mumbai 400083.
